Our studies identify a novel crosstalk between TGFβ and IGF-1R signaling through the adaptor protein, IRS-1, indicating that one of the mechanisms by which TGFβ elicits its tumor suppressor function is through inhibition of IRS-1 expression and activation in colon cancer cells. Here, IGF1R is linked to malignant colon neoplasm.